Suppr超能文献

10/10 HLA 匹配的无关供者造血干细胞移植中供者年龄与 HLA-DP 匹配的相互作用。

Interplay between donor age and HLA-DP matching in 10/10 HLA-matched unrelated donor HCT.

机构信息

Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.

Division of Translational Science and Therapeutics, Fred Hutchinson Cancer Center, Seattle, WA.

出版信息

Blood Adv. 2024 Oct 22;8(20):5438-5449. doi: 10.1182/bloodadvances.2024013677.

Abstract

In 10/10 HLA-matched unrelated donor (MUD) hematopoietic cell transplantation (HCT) with calcineurin-inhibitor (CNI)-based prophylaxis, T-cell epitope DP-matched and permissive mismatched donors are associated with similar overall survival (OS) whereas donors with nonpermissive mismatches should be avoided. Younger unrelated donors are also favored over older donors. We explored outcomes associated with different combinations of DP-matching and donor age (dichotomized at 35 years) to further guide donor selection. Using a Center for International Blood and Marrow Transplant Research data set, we categorized 10 783 patients into 6 groups: DP-matched/younger donor (n = 1591), DP-matched/older donor (n = 526), permissive-mismatched/younger donor (n = 3845), permissive-mismatched/older donor (n = 1184), nonpermissive mismatched/younger donor (n = 2659), and nonpermissive mismatched/older donor (n = 978). We noted that younger donor age, rather than DP matching, was associated with better OS. Younger donors with permissive mismatches were associated with improved OS compared with older matched donors. Furthermore, younger donors with nonpermissive mismatches were associated with improved OS compared with older donors with permissive mismatches. Our study adds further information about the association of DP matching and donor age with HCT outcomes. Donor age should be prioritized over DP matching in patients undergoing 10/10 HLA-MUD with CNI prophylaxis. Among those with younger donors, permissive-mismatched or DP-matched donors are preferred over nonpermissive mismatched donors.

摘要

在 10/10 人类白细胞抗原(HLA)匹配的无关供者(MUD)造血细胞移植(HCT)中,使用钙调神经磷酸酶抑制剂(CNI)为基础的预防方案,T 细胞表位 DP 匹配和允许性错配供者与相似的总生存(OS)相关,而应避免非允许性错配的供者。年轻的无关供者也优于年长的供者。我们探讨了 DP 匹配和供者年龄(以 35 岁为界分为两组)不同组合与结局的关系,以进一步指导供者选择。利用国际血液和骨髓移植研究中心(CIBMTR)的数据集,我们将 10783 例患者分为 6 组:DP 匹配/年轻供者(n=1591)、DP 匹配/年长供者(n=526)、允许性错配/年轻供者(n=3845)、允许性错配/年长供者(n=1184)、非允许性错配/年轻供者(n=2659)和非允许性错配/年长供者(n=978)。我们注意到,供者年龄而不是 DP 匹配与更好的 OS 相关。具有允许性错配的年轻供者与年长匹配供者相比,OS 改善。此外,与年长具有允许性错配的供者相比,具有非允许性错配的年轻供者与 OS 改善相关。我们的研究进一步提供了关于 DP 匹配和供者年龄与 HCT 结局关系的信息。在接受 10/10 HLA-MUD 和 CNI 预防方案的患者中,供者年龄应优先于 DP 匹配。在具有年轻供者的患者中,与非允许性错配供者相比,允许性错配或 DP 匹配的供者更受欢迎。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5873/11568750/f02806627449/BLOODA_ADV-2024-013677-ga1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验